Hess Midstream LP HESM
32.70 USD +0.26 (+0.80%)
At closeNov 3, 2026, 4:55 PM EST
32.80 +0.10 +0.31%
After hours · Nov 3, 4:55 PM ET
32.27 Day range 33.27
29.52 52-week range 41.44
- YTD
- -5.22%
- 1 year
- -5.13%
Analyst view
Consensus: underperform
Underperform
Price target (mean) 33.43 +2.2% upside
Now 32.70
- Target (low)
- 30.00
- Target (mean)
- 33.43
- Target (high)
- 40.00
Ratings (0m) 7 1 buy · 3 hold · 3 sell
- Strong buy1
- Buy0
- Hold3
- Sell2
- Strong sell1
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.94162 | 0.74299 – 1.18 | 0.72 | +30.8% | 404.33M | +0.0% | 3 |
| Next quarter | 0.58 | 0.52 – 0.64 | 0.68 | -14.7% | 326.84M | -16.2% | 2 |
| Current year | 3.13 | 2.93 – 3.35 | 2.86 | +9.3% | 1.60B | -1.2% | 3 |
| Next year | 2.69 | 2.10 – 3.60 | 3.13 | -13.9% | 1.36B | -15.4% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 23, 2026 | Raymond James | Upgrade | Market Perform | Outperform |
| Oct 13, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 13, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 13, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Oct 2, 2026 | JP Morgan | Downgrade | Neutral | Underweight |
| Jun 10, 2026 | Morgan Stanley | Downgrade | Equal-Weight | Underweight |
| May 12, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Apr 20, 2026 | Goldman Sachs | Downgrade | Neutral | Sell |
| Mar 13, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jan 5, 2026 | Raymond James | Downgrade | Outperform | Market Perform |
| Oct 24, 2025 | Raymond James | Reiterated | Outperform | Outperform |
| Sep 23, 2025 | Citigroup | Maintained | Neutral | Neutral |
| Sep 19, 2025 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Sep 11, 2025 | Citigroup | Downgrade | Buy | Neutral |
| Sep 10, 2025 | UBS | Downgrade | Buy | Neutral |
| Aug 22, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 1, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 25, 2025 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| May 1, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Mar 27, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Feb 18, 2025 | Citigroup | Maintained | Buy | Buy |
| Feb 4, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jan 30, 2025 | Raymond James | Reiterated | Outperform | Outperform |
| Jan 28, 2025 | Raymond James | Maintained | Outperform | Outperform |
| Aug 21, 2024 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 3, 2024 | UBS | Maintained | Buy | Buy |
| Apr 29, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Apr 16, 2024 | JP Morgan | Maintained | Neutral | Neutral |
| Mar 8, 2024 | JP Morgan | Downgrade | Overweight | Neutral |
| Mar 1, 2024 | UBS | Maintained | Buy | Buy |
